Jaka jest cena za In Veritas Medical Diagnostics, Inc. (IVME)

Cena za In Veritas Medical Diagnostics, Inc. (IVME) wynosi $0.0007

Jaka jest kapitalizacja rynkowa dla In Veritas Medical Diagnostics, Inc. (IVME)

Kapitalizacja rynkowa dla In Veritas Medical Diagnostics, Inc. (IVME) wynosi $42.26K

In Veritas Medical Diagnostics, Inc. (IVME) Podziały Akcji

In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.

Rok	Podział	Mnożnik	Skumulowany mnożnik
Za mało danych dla podanych dat.

Rok

Podział

Mnożnik

Skumulowany mnożnik

Za mało danych dla podanych dat.

Firma	Skumulowany mnożnik	Kraj
Clone Algo Technologies Inc. CATI.US	-	US
Worldwide Webb Acquisition Corp. WWAC.US	-	US
Gushen, Inc. GSHN.US	-	CN
Apollo Strategic Growth Capital APSG.US	-	US
Digital World Acquisition Corp. DWAC.US	-	US

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj